Investments
8Portfolio Exits
5
Want to inform investors similar to Baccharis Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Baccharis Capital Investments
8 Investments
Baccharis Capital has made 8 investments. Their latest investment was in Benten BioServices as part of their PIPE - II on April 4, 2003.

Baccharis Capital Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
4/18/2003 | PIPE - II | Benten BioServices | $10M | No | ||
6/20/2000 | Series B | |||||
1/24/2000 | Series B | |||||
12/8/1999 | Series C | |||||
12/7/1999 | Seed |
Date | 4/18/2003 | 6/20/2000 | 1/24/2000 | 12/8/1999 | 12/7/1999 |
---|---|---|---|---|---|
Round | PIPE - II | Series B | Series B | Series C | Seed |
Company | Benten BioServices | ||||
Amount | $10M | ||||
New? | No | ||||
Co-Investors | |||||
Sources |
Baccharis Capital Portfolio Exits
5 Portfolio Exits
Baccharis Capital has 5 portfolio exits. Their latest portfolio exit was Fran's Healthy Helpings on June 21, 2002.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
6/21/2002 | Acquired | ||||
Date | 6/21/2002 | ||||
---|---|---|---|---|---|
Exit | Acquired | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources |
Baccharis Capital Team
1 Team Member
Baccharis Capital has 1 team member, including current Managing Director, Noel Perry.
Name | Work History | Title | Status |
---|---|---|---|
Noel Perry | Managing Director | Current |
Name | Noel Perry |
---|---|
Work History | |
Title | Managing Director |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.